Capital International Investors’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-87,057
Closed -$48.8M 445
2020
Q4
$48.8M Buy
87,057
+23
+0% +$14.6K 0.01% 334
2020
Q3
$60.8M Hold
87,034
0.02% 308
2020
Q2
$68.8M Buy
87,034
+20,625
+31% +$15.6M 0.02% 283
2020
Q1
$39.5M Sell
66,409
-49,395
-43% -$48.1M 0.02% 282
2019
Q4
$132M Sell
115,804
-304,191
-72% -$331M 0.04% 214
2019
Q3
$500M Buy
419,995
+27,124
+7% +$41.4M 0.19% 123
2019
Q2
$647M Sell
392,871
-2,383
-0.6% -$4.12M 0.26% 104
2019
Q1
$806M Buy
395,254
+5,335
+1% +$9.39M 0.35% 81
2018
Q4
$501M Buy
389,919
+138,198
+55% +$212M 0.25% 102
2018
Q3
$476M Buy
251,721
+164,507
+189% +$340M 0.22% 119
2018
Q2
$177M Buy
87,214
+8,721
+11% +$19.9M 0.2% 122
2018
Q1
$174M Buy
+78,493
New +$200M 0.2% 123

Other funds holding BLUE

Capital International Investors's BLUE Position: Q1 2021 in Review

Capital International Investors sold out of bluebird bio (BLUE) in Q1 2021, closing a stake of 87,057 shares — an estimated $48.8M sold.

Capital International Investors first reported a position in BLUE in Q1 2018 and held it in 12 quarters. The position peaked at $806M in Q1 2019. 229 funds tracked by Wall St. Rank hold BLUE as of Q1 2021.

  • Capital International Investors reported no remaining bluebird bio position as of Q1 2021 after selling out during the quarter.
  • Capital International Investors sold 87,057 bluebird bio shares in Q1 2021, an estimated $48.8M.
  • Capital International Investors first reported a position in bluebird bio in Q1 2018 and held it in 12 quarters.
  • Capital International Investors's bluebird bio position peaked at $806M in Q1 2019.
  • 229 funds tracked by Wall St. Rank held bluebird bio as of Q1 2021.

Based on Capital International Investors's 13F filing for Q1 2021, filed 14 May 2021.